Cancer research, Leukemia, Myeloid leukemia, Stem cell and Kinome are his primary areas of study. Alessandro Datti has researched Cancer research in several fields, including Cell culture, Protein kinase B, Kinase and Internal medicine. The various areas that Alessandro Datti examines in his Myeloid leukemia study include Antileukemic agent and Pharmacology.
His work deals with themes such as Cell and Mitochondrion, which intersect with Stem cell. His study in Kinome is interdisciplinary in nature, drawing from both Regulator, Serrate-Jagged Proteins and Small interfering RNA. His biological study spans a wide range of topics, including Cancer stem cell, Virology and Mitochondrial biogenesis.
Alessandro Datti mainly focuses on Cancer research, Biochemistry, Cell biology, Pharmacology and Cell culture. His Cancer research research incorporates elements of Head and neck cancer, Apoptosis, Cell cycle, Kinase and In vivo. His Biochemistry research is multidisciplinary, incorporating elements of Molecular biology and Bone resorption.
Alessandro Datti works in the field of Cell biology, focusing on Mitochondrion in particular. Alessandro Datti combines subjects such as Daunorubicin, Leukemia, Myeloid leukemia and Stem cell with his study of Pharmacology. In Myeloid leukemia, Alessandro Datti works on issues like Progenitor cell, which are connected to Mitochondrial biogenesis.
The scientist’s investigation covers issues in Cancer research, Cell culture, In vivo, Cell biology and Cell cycle. His work carried out in the field of Cancer research brings together such families of science as Cancer, Breast cancer, Anaplastic thyroid cancer, Cell growth and Kinase. The Cell culture study combines topics in areas such as Head and neck cancer, Chemotherapy, Inhibitory postsynaptic potential, Pathology and High-throughput screening.
His In vivo study combines topics from a wide range of disciplines, such as Targeted therapy and Syk. His work in the fields of Cell biology, such as Mitochondrion, overlaps with other areas such as Germination. The study incorporates disciplines such as Tyrosine kinase and Myeloid leukemia in addition to Pharmacology.
His primary areas of investigation include Cancer research, PTEN, Breast cancer, PI3K/AKT/mTOR pathway and Cell biology. Alessandro Datti interconnects Soft tissue sarcoma, Protein kinase B, Cell growth, Cancer cell and Triple-negative breast cancer in the investigation of issues within Cancer research. His Triple-negative breast cancer research is multidisciplinary, incorporating perspectives in Cyclin-dependent kinase 1, Wee1, Regulation of gene expression and Kinome.
His PTEN research incorporates themes from Metastasis, Claudin-Low, Surgical oncology, Transplantation and Adenocarcinoma. Alessandro Datti has researched PI3K/AKT/mTOR pathway in several fields, including Bioinformatics, Leiomyosarcoma, Doxorubicin, Sarcoma and Kinase. He combines subjects such as Downregulation and upregulation and Neuroprotection with his study of Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
Payman Samavarchi-Tehrani;Azadeh Golipour;Azadeh Golipour;Laurent David;Hoon Ki Sung.
Cell Stem Cell (2010)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Škrtić;Shrivani Sriskanthadevan;Bozhena Jhas;Marinella Gebbia.
Cancer Cell (2011)
Systematic exploration of essential yeast gene function with temperature-sensitive mutants
Zhijian Li;Franco J. Vizeacoumar;Sondra Bahr;Jingjing Li.
Nature Biotechnology (2011)
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
Richard Marcotte;Kevin R. Brown;Fernando Suarez;Azin Sayad.
Cancer Discovery (2012)
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Yanina Eberhard;Sean P. McDermott;Xiaoming Wang;Marcela Gronda.
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
Mahadeo A. Sukhai;Swayam Prabha;Rose Hurren;Angela C. Rutledge.
Journal of Clinical Investigation (2013)
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
Eric A. Lee;Leonard Angka;Sarah-Grace Rota;Thomas Hanlon.
Cancer Research (2015)
High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer
Julia Izrailit;Hal K. Berman;Hal K. Berman;Alessandro Datti;Alessandro Datti;Jeffrey L. Wrana.
Proceedings of the National Academy of Sciences of the United States of America (2013)
The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination
Lara O'Donnell;Stephanie Panier;Stephanie Panier;Jan Wildenhain;Johnny M. Tkach.
Molecular Cell (2010)
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.
Craig D. Simpson;Imtiaz A. Mawji;Kika Anyiwe;Moyo A. Williams.
Cancer Research (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: